Targeted MRI/Ultrasound Beats Standard Biopsy to Detect High-Risk Prostate Cancer
University of Maryland Medical CenterTargeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study published today in JAMA.